AdaptHealth (AHCO) Return on Capital Employed (2018 - 2026)
AdaptHealth's (AHCO) quarterly Return on Capital Employed came in at 2.02% in Q1 2026, down 407.0% year-on-year from 0.66% in Q1 2025, and down 19.22% quarter-over-quarter from 2.5% in Q4 2025.
AdaptHealth (AHCO) Return on Capital Employed (2018 - 2026) Analysis & Trends
AdaptHealth's Return on Capital Employed history runs 9 years deep, the most recent figure standing at 2.02% for Q1 2026.
- On a quarterly basis, Return on Capital Employed fell 407.0% year-over-year to 2.02% in Q1 2026; TTM through Mar 2026 was 2.02%, a 407.0% decrease from a year earlier, with the FY2025 full-year figure at 2.46%, down 425.0% from the prior year.
- Return on Capital Employed slipped to 2.02% in Q1 2026 per AHCO's latest filing, from 2.5% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 7.08% in Q3 2025 and bottomed at 14.73% in Q2 2024.
- The 5-year median for Return on Capital Employed is 3.49% (2023), against an average of 0.3%.
- Across the five-year window, Return on Capital Employed slumped 1866 bps in 2023 and surged 2172 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 3.99% in 2022, then sank by 468 bps to 14.67% in 2023, then surged by 146 bps to 6.74% in 2024, then tumbled by 63 bps to 2.5% in 2025, then retreated by 19 bps to 2.02% in 2026.
- Per Business Quant, the three latest AHCO Return on Capital Employed figures stand at 2.02% (Q1 2026), 2.5% (Q4 2025), and 7.08% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AdaptHealth | 1.42 Bn | 1.38 Bn | 111.50 Mn | 2.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.02% |
| Dec 31, 2025 | 2.50% |
| Sep 30, 2025 | 7.08% |
| Jun 30, 2025 | 6.99% |
| Mar 31, 2025 | 6.08% |
| Dec 31, 2024 | 6.74% |
| Sep 30, 2024 | -1.31% |
| Jun 30, 2024 | -14.73% |
| Mar 31, 2024 | -14.30% |
| Dec 31, 2023 | -14.67% |
| Sep 30, 2023 | -7.84% |
| Jun 30, 2023 | 3.35% |
| Mar 31, 2023 | 3.49% |
| Dec 31, 2022 | 3.99% |
| Sep 30, 2022 | 4.90% |
| Jun 30, 2022 | 5.36% |
| Mar 31, 2022 | 5.47% |
| Dec 31, 2021 | 4.78% |
| Sep 30, 2021 | 4.30% |
| Jun 30, 2021 | 3.21% |